GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million people by the year 2060. Although there is currently no cure for AD, ...

Researchers developed CpGPT, a novel foundation model for DNA methylation analysis that captures sequence, positional, and ...

Alzheimer's disease is a progressive neurodegenerative disease that affects millions of people worldwide. Oxidative stress ...

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

These messages help us to move, think, and remember. In Alzheimer’s disease and dementia with Lewy bodies, nerve cells become damaged and lose their ability to send messages. Our nerve cells rely on ...

A study from Florida State University is the first to show a direct correlation between K. pneumoniae infection and Alzheimer ...

Researchers discovered alcohol use disorder (AUD) and Alzheimer's disease (AD) exhibit similar patterns of gene dysregulation, hinting that alcohol consumption may hasten Alzheimer’s progression.

Nearly 7 million Americans have Alzheimer's disease, and this number is predicted to double by 2060. While aging and genetic predisposition are the most important risk factors for Alzheimer's, ...

Diagnosis of Alzheimer’s Disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted.

Two blood tests currently in development have shown 'very high accuracy' in detecting tell-tale signs of Alzheimer's disease, ...

This article discusses a recent revision of the Alzheimer Association criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be ...